Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions

Journal of Neurocytology

Volumn 33, Issue 2, 2004, Pages 213-223

  Kramer, Brian C ^a   Mytilineou, Catherine ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOPAMINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL ULTRASTRUCTURE; CELLULAR DISTRIBUTION; CHROMATIN CONDENSATION; CONTROLLED STUDY; CYTOPATHOLOGY; FEMALE; IMMUNOREACTIVITY; NERVE CELL LESION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN LOCALIZATION; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA;

ANIMALS; APOPTOSIS; ASTROCYTES; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; NERVE DEGENERATION; NEURONS; OXIDATIVE STRESS; OXIDOPAMINE; PARKINSONIAN DISORDERS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

ANIMALIA;

EID: 3042830433     PISSN: 03004864     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NEUR.0000030696.62829.ec     Document Type: Article

References (42)

1. ABE-DOHMAE, S., HARADA, N., YAMADA, K. & TANAKA, R. (1993) Bcl-2 gene is highly expressed during neurogenesis in the central nervous system. Biochemistry and Biophysics Research Communications 191, 915-921.
2. ANGLADE, P., VYAS, S., JAVOY-AGID, F., HERRERO, M. T., MICHEL, P. P., MARQUEZ, J., MOUATT-PRIGENT, A., RUBERG, M., HIRSCH, E. C. & AGID, Y. (1997) Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histolology and Histopathology 12, 25-31.
3. BANATI, R. B., DANIEL, S. E. & BLUNT, S. B. (1998) Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Movement Disorders 13, 221-227.
4. BOISE, L. H., GONZALEZ-GARCIA, M., POSTEMA, C. E., DING, L., LINDSTEN, T., TURKA, L. A., MAO, X., NUNEZ, G. & THOMPSON, C. B. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597-608.
5. BRUCE-KELLER, A. J., BEGLEY, J. G., FU, W., BUTTERFIELD, D. A., BREDESEN, D. E., HUTCHINS, J. B., HENSLEY, K. & MATTSON, M. P. (1998) Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid beta-peptide. Journal of Neurochemistry 70, 31-39.
6. CASTREN, E., OHGA, Y., BERZAGHI, M. P., TZIMAGIORGIS, G., THOENEN, H. & LINDHOLM, D. (1994) bcl-2 messenger RNA is localized in neurons of the developing and adult rat brain. Neuroscience 61, 165-177.
7. CHITTENDEN, T., HARRINGTON, E. A., O'CONNOR, R., FLEMINGTON, C., LUTZ, R. J., EVAN, G. I. & GUILD, B. C. (1995) Induction of apoptosis by the Bcl-2 homologue Bak. Nature 374, 733-736.
8. DECKWERTH, T. L., ELLIOTT, J. L., KNUDSON, C. M., JOHNSON, E. M., JR., SNIDER, W. D. & KORSMEYER, S. J. (1996) BAX is required for neuronal death after trophic factor deprivation and during development. Neuron 17, 401-411.
9. DEXTER, D. T., CARTER, C. J., WELLS, F. R., JAVOYAGID, F., AGID, Y., LEES, A., JENNER, P. & MARSDEN, C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. Journal of Neurochemistry 52, 381-389.
10. DEXTER, D. T., HOLLEY, A. E., FLITTER, W. D., SLATER, T. F., WELLS, F. R., DANIEL, S. E., LEES, A. J., JENNER, P. & MARSDEN, C. D. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study. Movement Disorders 9, 92-97.
11. GONZALEZ-GARCIA, M., GARCIA, I., DING, L., S, O. S., BOISE, L. H., THOMPSON, C. B. & NUNEZ, G. (1995) Bcl-x is expressed in embryonic and postnatal neural tissues and functions to prevent neuronal cell death. Proceedings of the National Academy of Science USA 92, 4304-4308.
12. GONZALEZ-GARCIA, M., PEREZ-BALLESTERO, R., DING, L., DUAN, L., BOISE, L. H., THOMPSON, C. B. & NUNEZ, G. (1994) bcl-Xl is the major bcl-x mRNA form expressed during murine development and its product localizes to mitochondria. Development 120, 3033-3042.
13. GROSS, A., McDONNELL, J. M. & KORSMEYER, S. J. (1999) BCL-2 family members and the mitochondria in apoptosis. Genes and Development 13, 1899-1911.
14. HAJOS, F. & KALMAN, M. (1989) Distribution of glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes in the rat brain. II. Mesencephalon, rhombencephalon and spinal cord. Experimental Brain Research 78, 164-173.
15. HIRSCH, E. C., HUNOT, S., DAMIER, P., BRUGG, B., FAUCHEUX, B. A., MICHEL, P. P., RUBERG, M., MURIEL, M. P., MOUATT-PRIGENT, A. & AGID, Y. (1999) Glial cell participation in the degeneration of dopaminergic neurons in Parkinson's disease. Advances in Neurology 80, 9-18.
16. HOCHMAN, A., STERNIN, H., GORODIN, S., KORSMEYER, S., ZIV, I., MELAMED, E. & OFFEN, D. (1998) Enhanced oxidative stress and altered antioxidants in brains of Bcl-2- deficient mice. Journal of Neurochemistry 71, 741-748.
17. ICHITANI, Y., OKAMURA, H., MATSUMOTO, Y., NAGATSU, I. & IBATA, Y. (1991) Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum. Brain Research 549, 350-353.
18. JELLINGER, K. A. (2000) Cell death mechanisms in Parkinson's disease. Journal of Neural Transmission 107, 1-29.
19. JEON, B. S., JACKSON-LEWIS, V. & BURKE, R. E. (1995) 6-Hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death. Neurodegeneration 4, 131-137.
20. KANE, D. J., ORD, T., ANTON, R. & BREDESEN, D. E. (1995) Expression of bcl-2 inhibits necrotic neural cell death. Journal of Neuroscience Research 40, 269-275.
21. KERR, J. F., WYLLIE, A. H. & CURRIE, A. R. (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. British Journal of Cancer 26, 239-257.
22. KOSEL, S., EGENSPERGER, R., VON EITZEN, U., MEHRAEIN, P. & GRABBER, M. B. (1997) On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropathologica (Berlin) 93, 105-108.
23. KRAJEWSKI, S., KRAJEWSKA, M., SHABAIK, A., MIYASHITA, T., WANG, H. G. & REED, J. C. (1994) Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. American Journal of Pathology 145, 1323-1336.
24. KRAMER, B., YABUT, J., CHEONG, J., JNOBAPTISTE, R., ROBAKIS, T., OLANOW, C. & MYTILINEOU, C. (2002) Lipopolysaccharide prevents cell death caused by glutathione depletion: Possible mechanisms of protection. Neuroscience 114, 361.
25. KRAMER, B. C., GOLDMAN, A. D. & MYTILINEOU, C. (1999) Glial cell line derived neurotrophic factor promotes the recovery of dopamine neurons damaged by 6-hydroxydopamine in vitro. Brain Research 851, 221-227.
26. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. L. & RANDALL, R. J. (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193, 265-275.
27. MERRY, D. E. & KORSMEYER, S. J. (1997) Bcl-2 gene family in the nervous system. Annual Review of Neuroscience 20, 245-267.
28. MERRY, D. E., VEIS, D. J., HICKEY, W. F. & KORSMEYER, S. J. (1994) bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development 120, 301-311.
29. MINN, A. J., BOISE, L. H. & THOMPSON, C. B. (1996) Bcl-x(S) anatagonizes the protective effects of Bcl-x(L). Journal of Biological Chemistry 271, 6306-6312.
30. MOGI, M., HARADA, M., KONDO, T., MIZUNO, Y., NARABAYASHI, H., RIEDERER, P. & NAGATSU, T. (1996) bcl-2 protein is increased in the brain from parkinsonian patients. Neuroscience Letters 215, 137-139.
31. SASTRY, P. S. & RAO, K. S. (2000) Apoptosis and the nervous system. Journal of Neurochemistry 74, 1-20.
32. SAUER, H. & OERTEL, W. H. (1994) Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59, 401-415.
33. SCHAPIRA, A. H., MANN, V. M., COOPER, J. M., KRIGE, D., JENNER, P. J. & MARSDEN, C. D. (1992) Mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson's Disease Research Group. Annals of Neurology 32 (Suppl), S116-S124.
34. SHIMOHAMA, S., FUJIMOTO, S., SUMIDA, Y. & TANINO, H. (1998) Differential expression of rat brain bcl-2 family proteins in development and aging. Biochemical and Biophysical Research Communications 252, 92-96.
35. SIAN, J., DEXTER, D. T., LEES, A. J., DANIEL, S., AGID, Y., JAVOY-AGID, F., JENNER, P. & MARSDEN, C. D. (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Annals of Neurology 36, 348-355.
36. SOFIC, E., LANGE, K. W., JELLINGER, K. & RIEDERER, P. (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neuroscience Letters 142, 128-130.
37. TATTON, N. A. (2000) Increased caspase 3 and bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Experimental Neurology 166, 29-43.
38. TOMPKINS, M. M., BASGALL, E. J., ZAMRINI, E. & HILL, W. D. (1997) Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. American Journal of Pathology 150, 119-131.
39. WALZ, W. (2000) Controversy surrounding the existence of discrete functional classes of astrocytes in adult gray matter. Glia 31, 95-103.
40. YAMADA, M., MIZUGUCHI, M., NISHIMAKI, K., TAKASHIMA, S., IKEDA, K., OHTA, S. & TAKAHASHI, H. (2000) Localization of Bcl-xbeta in the developing and adult rat central nervous system. Journal of Neuroscience Research 60, 468-477.
41. YANG, E., ZHA, J., JOCKEL, J., BOISE, L. H., THOMPSON, C. B. & KORSMEYER, S. J. (1995) Bad, a heterodimeric partner for Bel-XL and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285-291.
42. ZILLES, K., HAJOS, F., KALMAN, M. & SCHLEICHER, A. (1991) Mapping of glial fibrillary acidic protein-immunoreactivity in the rat forebrain and mesencephalon by computerized image analysis. Journal of Comparative Neurology 308, 340-355.